CMA pauses pharma probes to focus on covid-19
The UK’s Competition and Markets Authority has “paused” two probes into suspected collusion in the pharmaceutical sector as it reallocates resources to deal with the coronavirus pandemic.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.